Ex vivo renal artery repair combined with cold perfusion protection is an operative technique for managing complex renal artery lesions. Most diseases of the renal artery are proximal, and typically treated either medically, by endovascular means, or surgically. When surgery of the main renal artery is required, it can typically be performed with warm renal ischemia times of <30 minutes. However, in more distal disease, which can involve the segmental branches, a much more complicated surgical reconstruction can be anticipated. This often will necessitate warm ischemia times of >45 minutes, and can lead to direct renal nephron damage. In this setting, the ex vivo technique with cold perfusion can allow for lengthy reconstructive times of several hours without any measurable harm to renal function. The technique can be performed with low morbidity and mortality, an excellent rate of renal salvage, and preservation of renal function.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1053/j.semvascsurg.2014.06.010 | DOI Listing |
J Endourol
January 2025
Faculty of Medicine, Department of Urology, Namik Kemal University, Tekirdag, Turkey.
Excessive kidney mobility is an underestimating challenge for surgeons during retrograde intrarenal surgery (RIRS) and extracorporeal shock wave lithotripsy (ESL). There is no technique approved as a gold standard procedure for reducing excessive kidney mobility. The study aimed to uncover predictive factors for determining excessive renal mobility by utilizing clinicodemographic characteristics and noncontrast computed tomography (NCCT) data.
View Article and Find Full Text PDFAnn Thorac Surg Short Rep
December 2023
Department of Cardiac Surgery, Hartford HealthCare Heart and Vascular Institute, Hartford, Connecticut.
Background: Prior studies have demonstrated a lower prevalence of postoperative atrial fibrillation (POAF) in Black, Hispanic, Asian, and Native American patients compared with White cohorts after coronary artery bypass grafting. We hypothesized that preoperative differences in left atrial size may explain this disparity.
Methods: We assessed the incidence of new POAF in 1218 patients (215 minority patients and 1003 White patients) undergoing isolated, first-time coronary artery bypass grafting from January 2017 through September 2022.
Ann Thorac Surg Short Rep
September 2024
Auton Lab, School of Computer Science, Carnegie Mellon University, Pittsburgh, Pennsylvania.
Background: Intraoperative physiologic parameters could offer predictive utility in evaluating risk of adverse postoperative events yet are not included in current standard risk models. This study examined whether the inclusion of continuous intraoperative data improved machine learning model predictions for multiple outcomes after coronary artery bypass grafting, including 30-day mortality, renal failure, reoperation, prolonged ventilation, and combined morbidity and mortality (MM).
Methods: The Society of Thoracic Surgeons (STS) database features and risk scores were combined with retrospectively gathered continuous intraoperative data from patients.
BMC Nephrol
January 2025
Department of Internal Medicine II, Universitätsmedizin (Halle), Medical Faculty of the Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Straße 40, 06120, Halle (Saale), Germany.
Background: Managing acute myocardial infarction (AMI) in patients with chronic kidney disease (CKD) or end-stage renal disease on dialysis (renal replacement therapy, RRT) presents challenges due to elevated complication risks. Concerns about contrast-related kidney damage may lead to the omission of guideline-directed therapies like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in this population.
Methods: We analysed German-DRG data of 2016 provided by the German Federal Bureau of Statistics (DESTATIS).
BMC Emerg Med
January 2025
Department of Emergency Medicine, Recep Tayyip Erdoğan University Training and Research Hospital, Rize, 53020, Turkey.
Background: The incidence of contrast-induced acute kidney injury (CI-AKI) in the general population ranges from 0.6 to 2.3%, whereas for specific high-risk patients, the incidence can reach more than 30-40%.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!